A group of plaintiffs, most of whom are not Massachusetts residents sued BMS in a Mass. State court, alleging that the company's drug, Plavix , had damaged their health. BMS is incorporated in Delaware and headquartered in New York, and it maintains substantial operations in both New York and New Jersey . Although it engages in business activities in Massachusetts and sells Plavix there , BMS did not develop , marketing strategy for , manufacture , label package or work in regulatory approval in the Commonwealth . And the nonresident plaintiffs did not allege that they obtained Plavix from a Mass store , or that they were treated for their injuries in Massachusetts . The Massachusetts Superior Court judge denied BMS's motion to dismiss the service of summons on the claims for lack of personal jurisdiction . The Court ruled that BMS's "wide ranging " contacts with the Commonwealth were enough to support a finding of specific jurisdiction over the claims brought by the nonresident plaintiffs . The Court reasoned concluded that the nonresidents ' claims were similar in many ways to the Massachusetts residents ' claims and because BMS engaged in other activities in the Commonwealth . As the Chief Justice of the Massachusetts Supreme Judicial Court issue your decision on the appeal by BMS of the decision .